Literature DB >> 17709384

pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation.

Francesca De Santa1, Sonia Albini, Eleonora Mezzaroma, Livio Baron, Armando Felsani, Maurizia Caruso.   

Abstract

The expression of retinoblastoma (pRb) and cyclin D3 proteins is highly induced during the process of skeletal myoblast differentiation. We have previously shown that cyclin D3 is nearly totally associated with hypophosphorylated pRb in differentiated myotubes, whereas Rb-/- myocytes fail to accumulate the cyclin D3 protein despite normal induction of cyclin D3 mRNA. Here we report that pRb promotes cyclin D3 protein accumulation in differentiating myoblasts by preventing cyclin D3 degradation. We show that cyclin D3 displays rapid turnover in proliferating myoblasts, which is positively regulated through glycogen synthase kinase 3beta (GSK-3beta)-mediated phosphorylation of cyclin D3 on Thr-283. We describe a novel interaction between pRb and cyclin D3 that maps to the C terminus of pRb and to a region of cyclin D3 proximal to the Thr-283 residue and provide evidence that the pRb-cyclin D3 complex formation in terminally differentiated myotubes hinders the access of GSK-3beta to cyclin D3, thus inhibiting Thr-283 phosphorylation. Interestingly, we observed that the ectopic expression of a stabilized cyclin D3 mutant in C2 myoblasts enhances muscle-specific gene expression; conversely, cyclin D3-null embryonic fibroblasts display impaired MyoD-induced myogenic differentiation. These results indicate that the pRb-dependent accumulation of cyclin D3 is functionally relevant to the process of skeletal muscle cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709384      PMCID: PMC2168908          DOI: 10.1128/MCB.02199-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.

Authors:  Catherine Favreau; Dominique Higuet; Jean-Claude Courvalin; Brigitte Buendia
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment.

Authors:  S Mittnacht; R A Weinberg
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

3.  Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

Authors:  W G Kaelin; D C Pallas; J A DeCaprio; F J Kaye; D M Livingston
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

Review 4.  Cell cycle exit upon myogenic differentiation.

Authors:  K Walsh; H Perlman
Journal:  Curr Opin Genet Dev       Date:  1997-10       Impact factor: 5.578

5.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

6.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.

Authors:  H Weintraub; S J Tapscott; R L Davis; M J Thayer; M A Adam; A B Lassar; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.

Authors:  Rocco Figliola; Rossella Maione
Journal:  J Cell Physiol       Date:  2004-09       Impact factor: 6.384

8.  Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy.

Authors:  Anne Rochat; Anne Fernandez; Marie Vandromme; Jeàn-Pierre Molès; Triston Bouschet; Gilles Carnac; Ned J C Lamb
Journal:  Mol Biol Cell       Date:  2004-07-28       Impact factor: 4.138

9.  A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation.

Authors:  Brett R Johnson; Ryan T Nitta; Richard L Frock; Leslie Mounkes; David A Barbie; Colin L Stewart; Ed Harlow; Brian K Kennedy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

10.  Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation.

Authors:  Michael S Huh; Maura H Parker; Anthony Scimè; Robin Parks; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2004-09-13       Impact factor: 10.539

View more
  15 in total

1.  Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

Authors:  Omana P Mathew; Kasturi Ranganna; Frank M Yatsu
Journal:  Biomed Pharmacother       Date:  2010-12       Impact factor: 6.529

2.  Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.

Authors:  Deshan Ren; Fei Liu; Guanjun Dong; Ming You; Jianjian Ji; Yahong Huang; Yayi Hou; Hongye Fan
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

3.  Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5.

Authors:  Hao Shi; Mayank Verma; Lei Zhang; Chen Dong; Richard A Flavell; Anton M Bennett
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

4.  GSK3β mediates muscle pathology in myotonic dystrophy.

Authors:  Karlie Jones; Christina Wei; Polina Iakova; Enrico Bugiardini; Christiane Schneider-Gold; Giovanni Meola; James Woodgett; James Killian; Nikolai A Timchenko; Lubov T Timchenko
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

5.  AMP-activated protein kinase regulates beta-catenin transcription via histone deacetylase 5.

Authors:  Jun-Xing Zhao; Wan-Fu Yue; Mei-Jun Zhu; Min Du
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

6.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.

Authors:  Courtney R Lavalle; Karla Bravo-Altamirano; Karthik V Giridhar; Jun Chen; Elizabeth Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  BMC Chem Biol       Date:  2010-05-05

7.  Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1.

Authors:  Elizabeth Salisbury; Keiko Sakai; Benedikt Schoser; Claudia Huichalaf; Christiane Schneider-Gold; Heather Nguyen; Gou-Li Wang; Jeffrey H Albrecht; Lubov T Timchenko
Journal:  Exp Cell Res       Date:  2008-05-10       Impact factor: 3.905

8.  Potential gene regulatory role for cyclin D3 in muscle cells.

Authors:  Fathima Athar; Veena K Parnaik
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

Review 9.  Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Authors:  Per Hydbring; Marcos Malumbres; Piotr Sicinski
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

10.  ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy.

Authors:  Rocío N Villar-Quiles; Fabio Catervi; Eva Cabet; Raul Juntas-Morales; Casie A Genetti; Teresa Gidaro; Asuman Koparir; Adnan Yüksel; Sandra Coppens; Nicolas Deconinck; Emma Pierce-Hoffman; Xavière Lornage; Julien Durigneux; Jocelyn Laporte; John Rendu; Norma B Romero; Alan H Beggs; Laurent Servais; Mireille Cossée; Montse Olivé; Johann Böhm; Isabelle Duband-Goulet; Ana Ferreiro
Journal:  Ann Neurol       Date:  2019-12-27       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.